Defined Culture Medium for Undifferentiated Human Embryonic Stem Cells

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current culture media for human embryonic stem cells (hESCs) pose challenges due to the presence of animal products, leading to immune responses, contamination risks, and unpredictable cell differentiation, necessitating a defined medium that supports growth without substantial differentiation and maintains pluripotency.

Innovation Solution

A culture medium comprising a basal medium, proteins from the tumor necrosis factor (TNF) family, the Wnt family, insulin, transferrin, and fibroblast growth factor (FGF), with optional albumin and chemically defined cholesterol, is used to support the growth of hESCs in an undifferentiated state, free from animal serum and feeder cells.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If animal products are used in hESC culture medium, then cell growth is supported, but immune responses and rejection occur upon transplantation

Engineering Contradiction:
Improvecell growthVSAvoidimmune response
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The invention extracts and removes animal-derived components (feeder cells, serum, animal products) from the culture medium, replacing them with defined化学成分. This eliminates the source of immunogenicity while maintaining cell growth support through alternative defined factors.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention changes the chemical composition parameters of the culture medium from undefined animal products to precisely defined化学成分, including specific growth factors, cytokines, and supplements at controlled concentrations. This transformation maintains biological activity while eliminating immunogenicity.

Inventive Principle:
Principle #35Parameter changes

2Productivity

If animal products are used in hESC culture medium, then cell growth is supported, but contamination risk increases

Engineering Contradiction:
Improvecell growthVSAvoidcontamination risk
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The invention removes animal-derived components (feeder cells, serum, animal products) from the culture system, replacing them with chemically defined components. This extraction eliminates potential sources of viral and prion contamination while maintaining cell growth support.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention creates a controlled, defined chemical environment that is inert regarding contamination. By using chemically defined components rather than biological animal products, the system eliminates living contaminants while providing necessary growth factors and nutrients.

Inventive Principle:
Principle #39Inert atmosphere (Inert environment)

3Productivity

If animal products are used in hESC culture medium, then cell growth is supported, but separation from hESCs becomes time-consuming

Engineering Contradiction:
Improvecell growthVSAvoidseparation time
Core Design Contradiction:
ProductivityVSLoss of time

Solution Approach 1:

The invention extracts and removes feeder cells and animal products from the culture medium, replacing them with chemically defined components. This eliminates the need for time-consuming separation procedures while maintaining cell growth support through alternative defined factors.

Inventive Principle:
Principle #2Taking out (Extraction)

4Productivity

If animal products are used in hESC culture medium, then cell growth is supported, but developmental studies become unpredictable

Engineering Contradiction:
Improvecell growthVSAvoiddifferentiation predictability
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The invention changes the culture medium from undefined animal products to precisely defined化学成分 with known concentrations and identities. This includes specific growth factors, cytokines, and supplements at controlled levels, enabling predictable control over cell differentiation and development while maintaining cell growth.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention segments the culture medium into discrete, individually controllable components. Each factor (growth factors, cytokines, supplements) can be independently optimized and adjusted to control specific aspects of cell behavior, enabling predictable differentiation outcomes while supporting cell growth.

Inventive Principle:
Principle #1Segmentation

Data Source

PatentUS9101590B2Defined culture conditions of human embryonic stem cells
Publication Date: 2015.08.11 YALE UNIVERSITY
  • US9101590B2 patent drawing
  • US9101590B2 patent drawing
  • US9101590B2 patent drawing

AI summary

The present invention relates to compositions and methods for culturing stem cells, particularly embryonic stem cells. Specifically, the invention relates to a culture medium that supports proliferation of substantially undifferentiated stem cells, while maintaining potency of the cells. An an embodiment, the culture medium is defined and supports proliferation of substantially undifferentiated embryonic stem cells in essentially serum free and feeder cell free conditions. Compositions for making the medium and methods using the culture medium are also provided.